Related Experiment Video
Updated: Jul 5, 2025
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
Mark W Sonderup1, Patrick S Kamath2, Yaw A Awuku3
1Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Insights
Cirrhosis, the end stage of liver disease, poses a significant health challenge in Sub-Saharan Africa. Early diagnosis and accessible management strategies are crucial for improving patient outcomes in this resource-limited region.
Area of Science:
- Hepatology
- Public Health
- Internal Medicine
Background:
- Cirrhosis is the advanced stage of chronic liver disease, prevalent in Sub-Saharan Africa due to viral hepatitis, alcohol, and rising metabolic dysfunction-associated steatotic liver disease (MASLD).
- Liver cirrhosis leads to significant morbidity and mortality, exacerbated by liver dysfunction and portal hypertension.
- Early diagnosis is vital, as compensated cirrhosis offers a better prognosis than decompensated cirrhosis.
Purpose of the Study:
- To highlight the challenges and feasible strategies for diagnosing and managing cirrhosis in resource-constrained settings like Sub-Saharan Africa.
- To emphasize the importance of addressing the underlying causes of liver disease and implementing policy interventions.
Main Methods:
- Review of current diagnostic and management approaches for cirrhosis in resource-limited environments.
- Discussion of less invasive and cost-effective interventions, including blood tests and transient elastography.
- Exploration of management strategies for decompensated cirrhosis, such as pharmacotherapy and lifestyle modifications.
Main Results:
- Cost-effective and less invasive diagnostic tools like blood tests and transient elastography are feasible in Sub-Saharan Africa.
- Established interventions for managing complications like ascites, variceal bleeding, and hepatic encephalopathy are available.
- Policy interventions targeting hepatitis B and C screening, alcohol reduction, and MASLD management are essential.
Conclusions:
- Effective management of cirrhosis in Sub-Saharan Africa relies on early diagnosis, accessible interventions, and addressing root causes.
- Strengthening regional centers of excellence for specialized procedures like liver transplantation is crucial.
- Policy-level changes and dedicated initiatives are key to improving the prognosis for patients with cirrhosis.
Abstract:
Cirrhosis represents the end stage of chronic liver disease. Sub-Saharan Africa, a resource-constrained region, has a high burden of chronic liver disease, with causes including chronic viral hepatitis, excessive alcohol use, and metabolic dysfunction-associated steatotic liver disease (MASLD), the risk of which is burgeoning. The development of liver cirrhosis predicts for morbidity and mortality, driven by both liver dysfunction and the consequences of portal hypertension. Compensated cirrhosis portends a better prognosis than decompensated cirrhosis, highlighting the need for the early diagnosis of cirrhosis and its causes. With resource challenges, the diagnosis and management of cirrhosis is demanding, but less costly and less invasive interventions with substantial benefits, ranging from simple blood tests to transient elastography, are feasible in such settings. Simple interventions are also available to manage the complex manifestations of decompensation, such as β blockers in variceal bleeding prophylaxis, salt restriction and appropriate diuretic use in ascites, and lactulose and generic rifaximin in hepatic encephalopathy. Ultimately, managing the underlying causative factors of liver disease is key in improving prognosis. Management demands expanded policy interventions to increase screening and treatment for hepatitis B and C and reduce alcohol use and the metabolic factors driving MASLD. Furthermore, the skills needed for more specialised interventions, such as transjugular intrahepatic portosystemic shunt procedures and even liver transplantation, warrant planning, increased capacity, and support for regional centres of excellence. Such centres are already being developed in sub-Saharan Africa, demonstrating what can be achieved with dedicated initiatives and individuals.
More Related Videos
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:24Esophageal Varices-I: Introduction